Table 3.
Grade ≥ 3 adverse events | Afatinib (%) | Pemetrexed-cisplatin (%) |
---|---|---|
Neutropenia | 0.4 | 18.0 |
Fatigue | 1.3 | 12.6 |
Anaemia | 0.4 | 6.3 |
Nausea | 0.9 | 3.6 |
Diarrhoea | 14.4 | 0.0 |
Rash | 16.2 | 0.0 |
Vomiting | 3.1 | 2.7 |
Source: Sequist et al, [6]
Grade ≥ 3 adverse events | Afatinib (%) | Pemetrexed-cisplatin (%) |
---|---|---|
Neutropenia | 0.4 | 18.0 |
Fatigue | 1.3 | 12.6 |
Anaemia | 0.4 | 6.3 |
Nausea | 0.9 | 3.6 |
Diarrhoea | 14.4 | 0.0 |
Rash | 16.2 | 0.0 |
Vomiting | 3.1 | 2.7 |
Source: Sequist et al, [6]